Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q84135709)
Watch
English
Treatment of rheumatoid arthritis: we are getting there
scientific article published on 26 June 2009
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19560809
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19560809%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
title
Treatment of rheumatoid arthritis: we are getting there
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19560809
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19560809%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
main subject
rheumatoid arthritis
1 reference
based on heuristic
inferred from title
author name string
Yusuf Yazici
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19560809
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19560809%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
language of work or name
English
0 references
publication date
26 June 2009
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19560809
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19560809%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
published in
The Lancet
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19560809
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19560809%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
volume
374
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19560809
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19560809%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
issue
9685
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19560809
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19560809%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
page(s)
178-180
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19560809
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19560809%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
cites work
Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960792-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960792-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960792-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960792-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960792-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to disease activity score and clinical disease activity index categories
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960792-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long term safety of methotrexate in routine clinical care: discontinuation is unusual and rarely the result of laboratory abnormalities.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960792-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Do rheumatoid arthritis patients in clinical practice benefit from switching from infliximab to a second tumor necrosis factor alpha inhibitor?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960792-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of switching between anti-TNF therapies on HAQ response in patients who do not respond to their first anti-TNF drug.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960792-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A survey of inclusion of the time element when reporting adverse effects in randomised controlled trials of cyclo-oxygenase-2 and tumour necrosis factor alpha inhibitors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960792-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Most tumour necrosis factor inhibitor trials in rheumatology are undeservedly called 'efficacy and safety' trials: a survey of power considerations
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960792-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0140-6736(09)60792-3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19560809
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19560809%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
PubMed publication ID
19560809
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19560809
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19560809%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit